PHOENIX, May 10, 2017 /PRNewswire/ — Alpine 4 Technologies Ltd. (ALPP), a technology and manufacturing holding company, announced today that its subsidiary, Quality Circuit Assembly (QCA), has won a production contract with an international medical device firm.  Initial discussions between the companies began in early February, 2017 with a product agreement finalized in late March, 2017 and expected production to begin in Q3 2017 once clinical trials are concluded.  QCA is excited to announce that this contract not only has the potential to generate several millions in revenue over the next 24 months, but also has the ability to grow exponentially in the following years.  QCA is ISO 13485 certified and places a major emphasis in gaining new medical device partnerships while continuing to provide the great quality they are known for in the industry.

About Alpine 4 Technologies Ltd.

ALPP is a publicly traded enterprise with business-related endeavors in Automotive Technologies, Electronics Manufacturing, Software and Energy Services.

Four principles at the core of their business are: Synergy. Innovation. Drive. Excellence.  At ALPP, they believe synergistic innovation drives excellence, and by anchoring these words to their combined experience and capabilities, they are able to aggressively pursue opportunities within and across vertical markets.  They deliver solutions that not only drive industry standards, but also increase value for its shareholders.

Contact: Kent B. Wilson CEO or Ian Kantrowitz, Director of Investor Relations

Forward-Looking Statements:

The information disclosed in this press release is made as of the date hereof and reflects Alpine 4 most current assessment of its historical financial performance. Actual financial results filed with the SEC may differ from those contained herein due to timing delays between the date of this release and confirmation of final audit results. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties, including the uncertainties surrounding the current market volatility, and other factors the Company identifies from time to time in its filings with the SEC. Although Alpine 4 believes that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Alpine 4 disclaims any intention or obligation to update the forward-looking statements for subsequent events.